You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSI-H

Showing 51 - 75 of 2,526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in United States (Intensity modulated radiation therapy (IMRT), Dostarlimab)

Recruiting
  • Endometrial Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jul 5, 2022

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Perioperative Immunotherapy in MSI-H Gastrointestinal Tumors

Not yet recruiting
  • To Evaluate the Safety and Effectiveness of Immunotherapy During the Perioperative Treatment Stage in MSI-H Gastrointestinal Cancer
  • No interventions
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 26, 2020

Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

Active, not recruiting
  • Advanced Solid Tumor
  • +3 more
  • TP-1454 monotherapy
  • TP-1454 combination therapy
  • Phoenix, Arizona
  • +8 more
Nov 18, 2022

MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer Trial (AK104)

Not yet recruiting
  • MSI-H/dMMR Gastric Carcinoma and Colorectal Cancer
  • (no location specified)
Sep 14, 2020

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Colorectal Tumors Trial in China (Pembrolizumab, Oxaliplatin, Leucovorin)

Recruiting
  • Colorectal Neoplasms
  • Pembrolizumab
  • +6 more
  • Beijing, Beijing, China
  • +21 more
Jan 25, 2023

Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite

Recruiting
  • Advanced Microsatellite Stable Colorectal Carcinoma
  • +5 more
  • Atlanta, Georgia
  • +2 more
Oct 29, 2021

The mCRC pMMR/MSS or dMMR/MSI-H Status Received Palliative

Completed
  • Colorectal Cancer Metastatic
  • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Jul 23, 2020

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer, Mismatch Repair Proficient Colorectal Cancer

    Active, not recruiting
    • Microsatellite Unstable Colorectal Cancer
    • +3 more
    • Gilbert, Arizona
    • +31 more
    Dec 21, 2021

    Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,

    Completed
    • Colorectal Cancer Metastatic
    • +6 more
    • EDP1503
    • Pembrolizumab
    • Rogers, Arkansas
    • +7 more
    Nov 11, 2021

    Colorectal Cancer Metastatic, MSI-H Colorectal Cancer Trial in France (Nivolumab, Ipilimumab)

    Recruiting
    • Colorectal Cancer Metastatic
    • MSI-H Colorectal Cancer
    • Avignon, France
    • +18 more
    Apr 6, 2021

    Colorectal Cancer Trial in Guangzhou (PD-1 antibody + cox inhibitor)

    Unknown status
    • Colorectal Cancer
    • PD-1 antibody + cox inhibitor
    • Guangzhou, Guangdong, China
    • +1 more
    Jun 25, 2020

    Colorectal Cancer Not MSI-H or MMR-deficient, GIST, Oesophageal or Gastric Carcinoma Trial in France (Phase 1 : Regorafenib,

    Recruiting
    • Colorectal Cancer Not MSI-H or MMR-deficient
    • +9 more
    • Phase 1 : Regorafenib
    • +4 more
    • Bordeaux, France
    • +6 more
    Dec 6, 2021

    Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)

    Recruiting
    • Colorectal Cancer
    • Pembrolizumab
    • +4 more
    • Orange City, Florida
    • +54 more
    Aug 17, 2022

    Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

    Recruiting
    • Breast Cancer
    • +15 more
    • ATRC-101
    • +2 more
    • Phoenix, Arizona
    • +10 more
    Sep 28, 2022

    Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,

    Active, not recruiting
    • Solid Tumor
    • +4 more
    • Nashville, Tennessee
    • +14 more
    Jul 21, 2022

    Advanced Malignant Tumor Trial in Shanghai, Chengdu (QL1604)

    Unknown status
    • Advanced Malignant Tumor
    • Shanghai, Shanghai, China
    • +1 more
    Mar 26, 2020

    Locally Advanced Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Irinotecan)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • PD-1 antibody
    • +3 more
    • Shanghai, Shanghai, China
      Zhen Zhang
    Jun 1, 2020

    Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

    Recruiting
    • Toripalimab
    • Radiation
    • Hangzhou, Zhejiang, China
      Zhengjiang Cancer Hospital
    Dec 29, 2022

    Locally Advanced Colon Cancer Trial in Xiamen (Toripalimab)

    Unknown status
    • Locally Advanced Colon Cancer
    • Xiamen, Fujian, China
      Yefeng
    May 11, 2020

    Advanced Solid Tumor, MSI-H/dMMR Tumors, Cutaneous Squamous Cell Carcinoma Trial in Worldwide (INCB099280)

    Recruiting
    • Advanced Solid Tumor
    • +11 more
    • Boston, Massachusetts
    • +30 more
    Dec 1, 2022

    MSI-H or dMMR Advanced Solid Tumors Trial in China (AK105, Anlotinib)

    Unknown status
    • MSI-H or dMMR Advanced Solid Tumors
    • Beijing, Beijing, China
    • +8 more
    Feb 28, 2020

    Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

    Recruiting
    • Melanoma
    • +4 more
    • Pembrolizumab
    • Aurora, Colorado
    • +18 more
    Jan 5, 2023